Almirall SA
MAD:ALM

Watchlist Manager
Almirall SA Logo
Almirall SA
MAD:ALM
Watchlist
Price: 8.15 EUR -0.24% Market Closed
Market Cap: 1.7B EUR
Have any thoughts about
Almirall SA?
Write Note

Almirall SA
Investor Relations

Almirall SA, a venerable player in the pharmaceutical industry, has its roots deeply embedded in the Spanish landscape where it began its journey in 1943. With a commitment to innovation and a keen focus on dermatology, the company has carved out a significant niche for itself. Almirall's core strategy revolves around the development, manufacturing, and commercialization of its proprietary medications, particularly those targeting skin conditions such as psoriasis and atopic dermatitis. By investing heavily in research and development, Almirall ensures its pipeline remains robust with promising drug candidates and innovative therapies that can meet the unmet needs of dermatology patients. This focus gives them a strategic edge, allowing them to leverage their scientific expertise and deliver state-of-the-art solutions to the market.

The financial health of Almirall thrives on a clear business model that involves both direct sales and strategic partnerships. Through collaborations with other pharmaceutical giants and dynamic distribution networks, the company expands its reach beyond Europe, tapping into the American and Asian markets as well. Licensing agreements and co-development partnerships are key to its financial strategy, effectively allowing Almirall to maximize its intellectual property while sharing risks and costs. This multi-pronged approach ensures a steady revenue stream from both its branded products and its generics division, which supplements the overall profitability and sustainability of the company. As Almirall continues to navigate the competitive landscape of the pharma industry, its resilience and adaptability underscore its enduring legacy.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Carlos Gallardo Piqué
CEO, President, Member of Management Board & Chairman of the Board
No Bio Available
Mr. Eloi Crespo Cervera
Chief Industrial Operations Officer & Member of Management Board
No Bio Available
Mr. Esteve Conesa Panicot
Chief People & Culture Officer and Member of Management Board
No Bio Available
Dr. Volker Koscielny
Chief Medical Officer & Member of Management Board
No Bio Available
Dr. Karl Ziegelbauer
Chief Scientific Officer & Member of Management Board
No Bio Available
Mr. Paolo Cionini
Chief Commercial Officer Europe & International and Member of Management Board
No Bio Available
Ms. Isabel Cristina Gomes
Company Vice Secretary,Chief Legal Officer, General Counsel & Member of Management Board
No Bio Available
Ms. Mercedes Diz Lopez
Chief Marketing Officer & Member of Management Board
No Bio Available
Mr. Paul Rittman
Member of Management Board and President & GM of Almirall US
No Bio Available
Mr. Pablo Divasson del Fraile
Senior Director of Investor Relations
No Bio Available

Contacts

Address
BARCELONA
Barcelona
Ronda General Mitre, 151
Contacts
+34932913000.0
www.almirall.es